These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7863248

  • 1. Nizatidine in therapy and prevention of non-steroidal anti-inflammatory drug-induced gastroduodenal ulcer in rheumatic patients.
    Simon B, Müller P.
    Scand J Gastroenterol Suppl; 1994; 206():25-8. PubMed ID: 7863248
    [Abstract] [Full Text] [Related]

  • 2. [Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients].
    Simon B, Leucht U, Amon I, Brandau J, Müller P.
    Z Gastroenterol; 1993 Jun; 31(6):395-400. PubMed ID: 8212757
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial.
    Naccaratto R, Cremer M, Dammann HG, Keohane PP, Mulder H, Sarles H, Simon B.
    Scand J Gastroenterol Suppl; 1987 Jun; 136():71-8. PubMed ID: 2892258
    [Abstract] [Full Text] [Related]

  • 5. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism].
    Simon B, Bergdolt H, Dammann H, Müller P.
    Z Gastroenterol; 1991 May; 29(5):217-21. PubMed ID: 1950028
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Yeomans ND.
    Am J Med; 1998 Mar 30; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322
    [Abstract] [Full Text] [Related]

  • 8. Omeprazole 20 or 40 mg daily for healing gastroduodenal ulcers in patients receiving non-steroidal anti-inflammatory drugs.
    Massimo Claar G, Monaco S, Del Veccho Blanco C, Capurso L, Fusillo M, Annibale B.
    Aliment Pharmacol Ther; 1998 May 30; 12(5):463-8. PubMed ID: 9663727
    [Abstract] [Full Text] [Related]

  • 9. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
    Kuipers EJ, Hazenberg HJ, Quik RF, Hazenberg BP, de Zwart PA.
    Neth J Med; 1990 Aug 30; 37(1-2):58-62. PubMed ID: 1977089
    [Abstract] [Full Text] [Related]

  • 10. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention.
    Rodríguez de la Serna A, Díaz-Rubio M.
    J Rheumatol; 1994 May 30; 21(5):927-33. PubMed ID: 8064736
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.
    Ekström P, Carling L, Wetterhus S, Wingren PE, Anker-Hansen O, Lundegårdh G, Thorhallsson E, Unge P.
    Scand J Gastroenterol; 1996 Aug 30; 31(8):753-8. PubMed ID: 8858742
    [Abstract] [Full Text] [Related]

  • 13. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I.
    Gut; 1996 Jul 30; 39(1):22-6. PubMed ID: 8881802
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
    Karateev AE, Murav'ev IuV, Radenska-Lopovok SG, Nasonova VA.
    Klin Med (Mosk); 2003 Jul 30; 81(8):37-41. PubMed ID: 14520944
    [Abstract] [Full Text] [Related]

  • 17. Nizatidine versus placebo in active benign gastric ulcer disease: an eight-week, multicenter, randomized, double-blind comparison. The Nizatidine Benign Gastric Ulcer Disease Study Group.
    Cloud ML, Enas N, Offen WW.
    Clin Pharmacol Ther; 1992 Sep 30; 52(3):307-13. PubMed ID: 1526089
    [Abstract] [Full Text] [Related]

  • 18. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis.
    Van Groenendael JH, Markusse HM, Dijkmans BA, Breedveld FC.
    Clin Rheumatol; 1996 Sep 30; 15(5):450-6. PubMed ID: 8894357
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of non-steroidal anti-inflammatory drug-induced damage to gastric mucosa using ranitidine. Comparison of the effectiveness of 2 dosages].
    Müller P, Dammann HG, Marinis E, Weise D, Simon B.
    Fortschr Med; 1989 Oct 30; 107(31):667-70. PubMed ID: 2687142
    [Abstract] [Full Text] [Related]

  • 20. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J, Blum AL, Bolten WW, Dragosics B, Rösch W, Stolte M, Koelz HR.
    Gut; 2002 Sep 30; 51(3):329-35. PubMed ID: 12171952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.